Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
Peter Reimer(Städtisches Klinikum Karlsruhe), Thomas Balzer
Cited by 613
Abstract
Related Papers
No related papers found
Powered by citation graph analysis